“Subclinical Left Ventricular Dysfunction Prevention in Breast Cancer Patients after FAC Chemotherapy: A Carvedilol Trial”, IJIHS, vol. 12, no. 1, pp. 55–64, Mar. 2024, doi: 10.15850/ijihs.v12.n1.3570.